Trial intelligence / Profile preview

Oral Mecobalamin for TKI-Associated Hand-Foot Syndrome in Advanced Thyroid Cancer

NCT07911891Phase 2Completed

Start
Apr 2025
Primary completion
Dec 2025
Countries
1
01

Overview

A Phase 2 trial of mecobalamin in hand-foot syndrome (HFS). Started Apr 2025; status: completed.

02

Drugs

mecobalamin
03

Conditions

hand-foot syndrome (HFS)

Beyond the preview

Go deeper on NCT07911891.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07911891.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call